KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Ionis Pharmaceuticals (IONS) over the last 13 years, with Q3 2025 value amounting to -$8.8 million.

  • Ionis Pharmaceuticals' Change in Account Payables fell 30943.75% to -$8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.1 million, marking a year-over-year increase of 34575.4%. This contributed to the annual value of $16.0 million for FY2024, which is 9694.54% up from last year.
  • Latest data reveals that Ionis Pharmaceuticals reported Change in Account Payables of -$8.8 million as of Q3 2025, which was down 30943.75% from -$20.4 million recorded in Q2 2025.
  • In the past 5 years, Ionis Pharmaceuticals' Change in Account Payables registered a high of $35.2 million during Q4 2024, and its lowest value of -$20.4 million during Q2 2025.
  • In the last 5 years, Ionis Pharmaceuticals' Change in Account Payables had a median value of -$2.2 million in 2024 and averaged -$521736.8.
  • As far as peak fluctuations go, Ionis Pharmaceuticals' Change in Account Payables crashed by 242822.38% in 2021, and later surged by 55603.81% in 2023.
  • Quarter analysis of 5 years shows Ionis Pharmaceuticals' Change in Account Payables stood at $4.7 million in 2021, then plummeted by 195.27% to -$4.5 million in 2022, then skyrocketed by 556.04% to $20.6 million in 2023, then soared by 71.06% to $35.2 million in 2024, then crashed by 125.02% to -$8.8 million in 2025.
  • Its last three reported values are -$8.8 million in Q3 2025, -$20.4 million for Q2 2025, and $92000.0 during Q1 2025.